Thomas Dalton - Cingulate Head Relations

CING Stock  USD 0.80  0.0001  0.01%   

Executive

Thomas Dalton is Head Relations of Cingulate
Address 1901 West 47th Place, Kansas City, KS, United States, 66205
Phone913 942 2300
Webhttps://www.cingulate.com

Cingulate Management Efficiency

The company has return on total asset (ROA) of (1.9098) % which means that it has lost $1.9098 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.1281) %, meaning that it created substantial loss on money invested by shareholders. Cingulate's management efficiency ratios could be used to measure how well Cingulate manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cingulate's Return On Capital Employed is most likely to slightly grow in the upcoming years. The Cingulate's current Return On Equity is estimated to increase to 3.60, while Return On Tangible Assets are forecasted to increase to (6.40). The Cingulate's current Debt To Assets is estimated to increase to 1.06, while Total Assets are projected to decrease to roughly 3.3 M.
The company currently holds 3.51 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Cingulate has a current ratio of 10.72, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cingulate until it has trouble settling it off, either with new capital or with free cash flow. So, Cingulate's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cingulate sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cingulate to invest in growth at high rates of return. When we think about Cingulate's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

EXECUTIVE Age

Quinton McGeerBarloworld Ltd ADR
58
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficithyperactivity disorder. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Cingulate operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. Cingulate (CING) is traded on NASDAQ Exchange in USA. It is located in 1901 West 47th Place, Kansas City, KS, United States, 66205 and employs 13 people. Cingulate is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Cingulate Leadership Team

Elected by the shareholders, the Cingulate's board of directors comprises two types of representatives: Cingulate inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate's management team and ensure that shareholders' interests are well served. Cingulate's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate's outside directors are responsible for providing unbiased perspectives on the board's policies.
Craig Esq, Gen VP
Dr MBA, Executive COO
Raul MD, Executive Officer
Thomas Dalton, Head Relations
Jennifer CPA, Senior CFO
PharmD PharmD, Principal CEO
Jennifer Callahan, Corporate Controller
Matthew MD, Executive Officer

Cingulate Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cingulate a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Cingulate's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(26.00)
Return On Assets
(1.91)
Return On Equity
(5.13)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.